Introduction
============

Lumbar disc degeneration (LDD) is a worldwide orthopedic disease. In particular, 80--90% of the population aged over 60 years are suffering from LDD. LDD is a common disease affecting the health of the elderly ([@b1-etm-0-0-6382],[@b2-etm-0-0-6382]). The pathogenesis of LDD is relatively complicated, and the risk factors are not only related to the external environment and labor involved, but also closely associated with the genetic factors of the body. Recent studies have reported that multiple human genetic mutations can make lumbar disc more susceptible to disease ([@b3-etm-0-0-6382]). Growth differentiation factor 5 (GDF5) is a transforming growth factor, which is a key protein factor in the growth and development of bone and cartilage and plays an important role in the formation of bone, especially joint ([@b4-etm-0-0-6382],[@b5-etm-0-0-6382]). Some findings have revealed that GDF5 can affect the expression of isotypic collagenase gene by virtue of the multiple differentiation and proliferation abilities of stem cells, thereby improving the structure of the lumbar disc in rats ([@b6-etm-0-0-6382]). As a single nucleotide polymorphism (SNP) site in *GDF5* gene, rs143383 is located in 5′ non-coding region of *GDF5* gene, and a mutation at this site is sure to result in downregulated gene expression, decreasing *GDF5* gene expression in the body, thereby increasing the onset risk of LDD ([@b7-etm-0-0-6382],[@b8-etm-0-0-6382]). This study investigated the correlation between SNP rs143383 in GDF5 and LDD.

Materials and methods
=====================

### General data

A total of 210 patients with LDD diagnosed and treated in Shanghai General Hospital of Nanjing Medical University (Shanghai, China) from August 2013 to March 2017 were randomly selected as observation group, and 320 patients without lumbar diseases diagnosed and treated in the hospital during the same period were randomly selected as control group. In the observation group, there were 120 males and 90 females aged 39--81 years, with mean age of 64.2±19.3 years. Among them, in terms of Thompson\'s pathological grading, there were 21 cases of Grade I, 45 cases of Grade II, 38 cases of Grade III, 56 cases of Grade IV and 50 cases of Grade V. Control group had 190 males and 130 females aged 37--83 years, whose mean age was 65.5±19.7 years. All patients were aware of this study and signed the informed consent, and this study was approved by the Ethics Committee of Shanghai General Hospital of Nanjing Medical University. There were no statistically significant differences in sex, age, living habits, between he two groups (P\>0.05) ([Table I](#tI-etm-0-0-6382){ref-type="table"}), and the results were comparable.

### Extraction of genomic deoxyribonucleic acid (DNA)

Whole blood (5 ml) was collected from each patient with an anticoagulant tube containing ethylenediamine tetraacetic acid dipotassium (EDTAK2). Then, genomic DNA was extracted from the blood using an Omega Mag-Binds Forensic DNA kit (Omega Bio-Tek, Inc., Norcross, GA, USA). After that, the concentration and purity of DNA were determined by NanoDrop, and DNA was stored at −20°C.

### SNP typing via polymerase chain reaction (PCR)

Primer sequences and their Taqman probe sequences at SNP site ([Table II](#tII-etm-0-0-6382){ref-type="table"}) designed by Oligo6.0 were used. Primer synthesis was accomplished by Sangon Biotech Co., Ltd. (Shanghai, China). DNA solution (1 µl) and 1.2 µl prepared primer solution (including 0.4 µl upstream primer, 0.4 µl downstream primer and 0.4 µl probe primer) were added to 17.8 µl pre-prepared TransStart Probe qPCR SuperMix (Beijing TransGen Biotech Co., Ltd., Beijing, China), slightly shaken to mix, and placed into a CFX96 fluorescent quantitative PCR instrument (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Reaction conditions: i) 94°C for 3 min, for 1 cycle; ii) 94°C for 15 sec and 60°C for 60 sec, for 42 cycles. After each cycle, the fluorescence value was read once. The experimental results were generated by built-in software of the instrument. Three replicate wells were made for each sample, diethyl pyrocarbonate (DEPC) water was used as negative control, and positive plasmid containing the sequence (synthesized by Sangon Biotech) was used as positive control. Determination of genotypes: The wild homozygous genotype was near the FAM abscissa, the mutant homozygous genotype was near the VIC ordinate, and the heterozygous genotype was near the 45° line.

### Statistical analysis

Statistical Product and Service Solutions (SPSS; IBM Corp., Armonk, NY, USA) 19.0 software was used for statistical analysis. Chi-square test was employed for statistical analyses of genotype distribution differences between case group and control group. Logistic regression analysis was adopted for the associations between various genotypes and the risk of LDD. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Distributions of genotypes at rs143383 in two groups

A total of 210 patients with LDD and 320 patients in control group obtained clear genotyping results ([Fig. 1](#f1-etm-0-0-6382){ref-type="fig"}). There were no statistically significant differences in distribution frequency of two genotypes, namely, TT and TC, at site rs143383 between LDD patient group and control group (P\>0.05), but the distribution frequency of CC genotype at rs143383 in LDD patient group showed a statistically significant difference compared with that in control group (P\<0.05) ([Table III](#tIII-etm-0-0-6382){ref-type="table"}). The distributions in two groups were in line with Hardy-Weinberg equilibrium \[P(control)=0.31 and P(observation)=0.35\].

### Onset risks of LDD analyzed in different models

In dominant models, odds ratio (OR) of (TC+CC/TT) was 1.195 (P=0.532). In recessive models, OR of (CC/TT+TC) was 4.333 (P=0.028). In co-dominant models, ORs of (TC/TT) and (CC/TT) were 0.967 and 4.43, respectively (P=0.09) ([Table IV](#tIV-etm-0-0-6382){ref-type="table"}).

### Association between genotypes at rs143383 and clinicopathologic grade of LDD

There were no statistically significant differences in three genotypes (TT, TC and CC) among different pathological grades (Grade I--V) (χ^2^=1.034, P=0.998), and the differences in T and C also showed no statistical significance (χ^2^=0.012, P=0.999) ([Table V](#tV-etm-0-0-6382){ref-type="table"}).

### Associations between different models and clinicopathologic grades of LDD using logistic regression analysis

Pathological grades in dominant models, recessive models and co-dominant models were analyzed, and the results showed that there were no statistically significant differences among pathological grades in dominant models, as well as in recessive models and co-dominant models. (P\>0.05) ([Table VI](#tVI-etm-0-0-6382){ref-type="table"}).

Discussion
==========

The expression function of genes may be influenced by many factors including the effects of non-coding regions and various regulators and the changes of gene structure caused by SNP in gene, affecting the action of translation function, indirectly influencing health, and leading to a variety of diseases ([@b9-etm-0-0-6382],[@b10-etm-0-0-6382]). Therefore, predicting the risks of associated diseases via statistical analyses of SNPs in the body becomes very meaningful. rs143383 is located in 5′ non-coding region of *GDF5* gene, where the promoter of gene manipulation system is located, so the regulation of *GDF5* gene expression will inevitably be affected ([@b11-etm-0-0-6382]). Moreover, the main function of *GDF5* gene is to code transforming factors that are closely related to the regeneration and formation of bone. Therefore, rs143383 polymorphism is certainly associated with bone-related diseases ([@b12-etm-0-0-6382],[@b13-etm-0-0-6382]). The incidence of LDD is mainly correlated with following factors: age is increased, the rate of bone formation is lower than that of bone loss, osteoporosis occurs, the elasticity of bone deteriorates, the ability to withstand load declines, and fracture and dislocation occur easily due to external pressure ([@b14-etm-0-0-6382]). Recent studies have found that mutations in *GDF5* gene are highly correlated with osteoarthritis, developmental dysplasia of hip and lumbar disc-related diseases ([@b15-etm-0-0-6382]).

Yin *et al* ([@b16-etm-0-0-6382]) used a variety of SNP typing methods and reported that Taqman probe method has an irreplaceable advantage in terms of the accuracy of typing. In this study, this method was used, and good genotyping results were obtained in patients with LDD and patients in control group. Tsezou ([@b17-etm-0-0-6382]) demonstrated that C/T at rs143383 is highly associated with LDD in White Europeans. This study found that CC genotype at rs143383 had very high association and risk with LDD in Chinese Han population with LDD. Among them, OR of (CC/TT+TC) was 4.333 (P=0.028) in recessive models, and OR of (CC/TT) was 4.43 (P=0.021) in co-dominant models. A study by Huétink *et al* ([@b18-etm-0-0-6382]) suggested that there is a certain association between *GDF5* gene and the severity of osteoarthritis in White Europeans. However, no significant differences were found in CC, CT and TT genotypes among different pathological grades (Grade I--V) in Chinese Han population (χ^2^=1.034, P=0.998), and there were also no statistically significant differences in T and C (χ^2^=0.012, P=0.999). In addition, no significant differences were found in dominant models, recessive models and over dominant models among different pathological grades (P\>0.05). It is possible that SNP mutations in *GDF5* gene have various effects on different bone diseases in different ethnic groups. Therefore, it is necessary to analyze the correlations between base mutations and LDD in different populations. Furthermore, there may be some differences in the results of the associations between SNP and diseases due to diverse sample sizes, so a larger sample size is more meaningful ([@b19-etm-0-0-6382],[@b20-etm-0-0-6382]).

In conclusion, CC mutant type at rs143383 in *GDF5* gene is strongly associated with the incidence of LDD and has a higher prevalence risk, but it is not significantly correlated with pathological grade.
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###### 

General clinical data.

  Parameters                        Observation group (n=210)   Control group (n=320)   P-value
  --------------------------------- --------------------------- ----------------------- ---------
  Age (years)                       64.2±19.3                   65.5±19.7               0.462
  Sex                                                                                   0.733
    Male                            120 (57.1%)                 190 (59.4%)             
    Female                            90 (42.9%)                130 (40.6%)             
  Body mass index (BMI) (kg/m^2^)   23.4±3.6                    23.6±3.8                0.754
  Smoking                                                                               0.415
    Yes                               86 (41%)                  137 (42.8%)             
    No                              124 (59%)                   183 (57.2%)             
  Drinking                                                                              0.536
    Yes                             121 (57.6%)                 191 (59.7%)             
    No                              89 (42.4%)                  129 (40.3%)             

###### 

Primer sequences.

  SNP        Primer sequence                            Probe sequence
  ---------- ------------------------------------------ -----------------------------------
  rs143383   Upstream: 5′-CAGGCAGCATTACGCCATTCTTC-3′    FAM: 5′-CGGTCGGCTTTCTCCTTTCAAG-3′
             Downstream: 5′-CACCGTCTCCAGTCAGCAGCTG-3′   VIC: 5′-CGGTTGGCTTTCTCCTTTCAAG-3′

###### 

Distribution frequency at rs143383 (n, %).

       Observation group (n=210)   Control group (n=320)                         
  ---- --------------------------- ----------------------- ----- ------- ------- -------
  TT   125                         59.5                    204   63.8    0.391   0.532
  TC     64                        30.5                    108   33.7    0.235   0.628
  CC     21                        10                        8     2.5   4.8     0.028
  T    314                         74.8                    516   80.6    0.971   0.324
  C    106                         25.2                    124   19.4            

###### 

Onset risks of LDD analyzed in different models.

  Model type          Genotype   Observation group (n=210)   Control group (n=320)   OR value \[95% confidence interval (CI)\]   P-value
  ------------------- ---------- --------------------------- ----------------------- ------------------------------------------- ---------
  Dominant model      TT         125                         204                     1                                           0.532
                      TC+CC        85                        116                     1.195 (0.732--1.532)                        
  Recessive model     TT+TC      189                         312                     1                                           0.028
                      CC           21                          8                     4.333 (2.321--7.786)                        
  Co-dominant model   TT         125                         204                     1                                           0.09
                      TC           64                        108                     0.967 (0.657--1.214)                        
                      CC           21                          8                     4.43 (2.451--7.698)                         

###### 

Genotypes at rs143383 and distributions of clinicopathologic grades in LDD patients (n, %).

                 rs143383                                       
  --------- ---- ----------- ----------- ---------- ----------- -----------
  I         36   21 (16.8)   12 (18.8)   3 (14.3)   54 (17.2)   18 (17)
  II        48   29 (23.2)   14 (21.9)   5 (23.8)   72 (22.9)   24 (22.6)
  III       41   24 (19.2)   13 (20.3)   4 (19)     61 (19.4)   21 (19.8)
  IV        45   27 (21.6)   13 (20.3)   5 (23.8)   67 (21.3)   23 (21.7)
  V         40   24 (19.2)   12 (18.8)   4 (19)     60 (19.1)   20 (18.9)
  χ^2^                       1.034                  1.012       
  P-value                    0.998                  0.999       

###### 

Associations between different models and clinicopathologic grades of LDD (n, %).

  Model type          Genotype   Grade I (36)   Grade II (48)   Grade III (41)   Grade IV (45)   Grade V (40)   P-value
  ------------------- ---------- -------------- --------------- ---------------- --------------- -------------- ---------
  Dominant model      TT         21 (16.8)      29 (23.2)       24 (19.2)        27 (21.6)       24 (19.2)      0.999
                      TC+CC      15 (17.6)      19 (22.4)       17 (20)          18 (21.2)       16 (18.8)      
  Recessive model     TT+TC      33 (17.5)      43 (22.8)       37 (19.6)        40 (21.2)       36 (19)        0.975
                      CC           3 (14.3)       5 (23.8)      4 (19)             5 (23.8)      4 (19)         
  Co-dominant model   TC         12 (18.8)      14 (21.9)       13 (20.3)        13 (20.3)       12 (18.8)      0.990
                      TT+CC      24 (16.4)      34 (23.3)       28 (19.2)        32 (21.9)       28 (19.2)      
